Rankings
▼
Calendar
KMDA
Kamada Ltd.
$495M
Q2 2022 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$24M
-2.7% YoY
Gross Profit
$7M
30.7% margin
Operating Income
-$2M
-9.7% margin
Net Income
-$4M
-16.6% margin
EPS (Diluted)
$-0.09
QoQ Revenue Growth
-16.0%
Cash Flow
Operating Cash Flow
$11M
Free Cash Flow
$10M
Stock-Based Comp.
$376,000
Balance Sheet
Total Assets
$304M
Total Liabilities
$133M
Stockholders' Equity
$172M
Cash & Equivalents
$30M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$24M
$24M
-2.7%
Gross Profit
$7M
$9M
-20.2%
Operating Income
-$2M
$1M
-319.3%
Net Income
-$4M
$937,000
-518.5%
← FY 2022
All Quarters
Q3 2022 →
KMDA Q2 2022 Earnings — Kamada Ltd. Revenue & Financial Results | Market Cap Arena